Zevra Therapeutics, Inc. (ZVRA) Return on equity 2021–2025
Zevra Therapeutics, Inc. (ZVRA) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
53.8%FY2025 · since FY2021: -8.4% → 53.8%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 53.8% | +319.8 pp |
| FY2024 | -266.0% | -191.6 pp |
| FY2023 | -74.4% | -38.8 pp |
| FY2022 | -35.6% | -27.2 pp |
| FY2021 | -8.4% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice